{"schema_version":"1","generated_at":"2026-10-28T05:38:24.994Z","data_as_of":null,"url":"https://www.findmykol.com/kol/benjamin-mizukawa","json_url":"https://www.findmykol.com/kol/benjamin-mizukawa/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"benjamin-mizukawa","name":"Benjamin Mizukawa","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cincinnati Children's Hospital Medical Center","institution_url":"https://www.findmykol.com/institution/cincinnati-children-s-hospital-medical-center","city":"Cincinnati","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1013113539","orcid":"0000-0002-3312-2982","openalex":"A5035455886"},"summary":"Benjamin Mizukawa is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 68 publications with 1,634 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":68,"cited_by_count":1634,"h_index":17,"latest_activity_year":2024,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06541847","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1","phase":"PHASE2","status":"RECRUITING","role":"Site investigator","sponsor":"Healx Limited","source_url":"https://clinicaltrials.gov/study/NCT06541847","trial_url":"https://www.findmykol.com/trial/NCT06541847"}],"source":"trials"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Other protein kinase inhibitors","setting":"prescribed","share_pct":100,"drugs":[{"name":"Xospata","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation","year":2024,"journal":"Cell Reports","source_url":"https://doi.org/10.1016/j.celrep.2024.114536","status":"verified"},{"title":"Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients","year":2024,"journal":"British Journal of Haematology","source_url":"https://doi.org/10.1111/bjh.19679","status":"verified"},{"title":"GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosis","year":2024,"journal":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","source_url":"https://doi.org/10.1016/j.bbadis.2024.167565","status":"verified"},{"title":"The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL","year":2023,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2023.02.012","status":"verified"},{"title":"Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy","year":2023,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.30214","status":"verified"}],"source":"works"},"contact":{"address_1":"3333 BURNET AVE","address_2":"MLC 7013","city":"Cincinnati","state":"OH","zip":"452293039","phone":"513-636-1335","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1013113539","source":"identity"},"similar":[{"name":"Andrea Beaton","slug":"andrea-beaton","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/andrea-beaton","json_url":"https://www.findmykol.com/kol/andrea-beaton/profile.json"},{"name":"Prasad Devarajan","slug":"prasad-devarajan","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/prasad-devarajan","json_url":"https://www.findmykol.com/kol/prasad-devarajan/profile.json"},{"name":"Stuart Goldstein","slug":"stuart-goldstein","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/stuart-goldstein","json_url":"https://www.findmykol.com/kol/stuart-goldstein/profile.json"},{"name":"Tracy Glauser","slug":"tracy-glauser","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/tracy-glauser","json_url":"https://www.findmykol.com/kol/tracy-glauser/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-04-13","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}